In support, the pro-tumor activity of the inflammasome can be proven by the blockade of IL-1β using Anakinra, which proved to prolong the PFS of myeloma patients through the reduction of IL-6 levels, crucial for tumor cell proliferation and survival [62]. Here, IL6 is linked to plasma cell myeloma.